Related Experiment Video
Updated: Feb 15, 2026
08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
2.3K
Malignant mesothelioma in situ.
Andrew Churg1, Harry Hwang2, Larry Tan3
1Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.
Histopathology
|January 20, 2018
Summary
Researchers identified potential malignant mesothelioma in situ (MIS) by analyzing genomic alterations in mesothelial cells. These findings suggest MIS may exist with subtle morphological changes, requiring further investigation into its development and frequency.
Area of Science:
- Oncology
- Genomics
- Pathology
Background:
- Malignant mesothelioma in situ (MIS) is a hypothesized precursor to invasive mesothelioma.
- Currently, no established morphological criteria exist for diagnosing MIS.
Observation:
- Two cases presented with subtle mesothelial changes and molecular alterations characteristic of invasive mesothelioma.
- One patient had unexplained pleural effusions with normal-appearing pleura on thoracoscopy, yet biopsies revealed BAP1 loss and CDKN2A deletion in mesothelial cells.
- The second patient presented with ascites, and omental biopsies showed minimally atypical mesothelial cells with BAP1 loss and CDKN2A deletion.
Findings:
- The study identified morphologically bland, single-layered mesothelial proliferations with molecular hallmarks of malignancy (BAP1 loss, CDKN2A deletion).
- Genomic analysis, including fluorescence in-situ hybridization (FISH), revealed specific genetic alterations in these mesothelial cells.
- These molecular findings suggest the presence of in-situ malignant transformation within the mesothelium.
Implications:
- These findings support the existence of malignant mesothelioma in situ (MIS).
- Further research with more cases is needed to determine the frequency and natural history of MIS.
- Understanding MIS could lead to earlier detection and improved management of malignant mesothelioma.
Related Concept Videos
02:31In-situ Hybridization
10.6K
In situ hybridization (ISH) is a technique used to detect and localize specific DNA or RNA molecules in cells, tissue, or tissue sections using a labeled probe. The technique was first used in 1969 for the investigation of nucleic acids. It is currently an essential tool in scientific research and clinical settings, especially for diagnostic purposes.
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...
10.6K
02:07FISH - Fluorescent In-situ Hybridization
24.6K
Fluorescence in situ hybridization, or FISH, was developed in the early 1980s and has quickly become one of the most widely used techniques in cytogenetics. Labeled probes are used to bind complementary DNA or RNA sequences on a chromosome or in a region within a cell. Earlier, the probes could only be obtained by cloning or reverse transcription of a DNA template. Currently, the probe oligonucleotides can be synthesized synthetically. Additionally, with the advancement of optical techniques,...
24.6K
01:09Methods for Studying Drug Absorption: In situ
708
In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
708